Nexsen Pruet announced today that Matt DeAntonio has joined the firm’s Charlotte office as an Associate of the Business Litigation Practice Group.

With a focus on commercial disputes, DeAntonio advises a wide range of clients in a number of diverse industries, including manufacturing, broadcasting and motorsports.  He advises corporate entities on disputes related to mergers and acquisitions as well as in settlement negotiations and mediations.

Val Stieglitz, Chair of Nexsen Pruet’s Business Litigation Practice Group, said Matt addition reinforces the firm’s ability to attract some of the brightest young attorneys the Carolinas has to offer.  

“Matt is an outstanding young lawyer with impressive technical abilities and a broad legal understanding,” Stieglitz explained.  “His strengths in handling commercial disputes, coupled with his solid educational background, make him a valuable addition to the Business Litigation Practice Group.” 

DeAntonio comes to Nexsen Pruet from one of the largest international firms in the world and will work closely with litigators Will Terpening and Chris Lam, who joined the firm’s Charlotte office in March.  These hires are part of Nexsen Pruet’s continuing expansion in North Carolina, which has now attracted 15 new attorneys since the start of 2011.

DeAntonio earned his bachelor and law degree, cum laude, from the University of South Carolina and the University of South Carolina School of Law.

Leonid graduated from the Lviv National Danylo Galytsky Medical University with specialization in clinical pharmacy. His legal degree he obtained at the Lviv National Ivan Franko University with specialization in civil law.

Leonid Shylovsky has an impressive Life Science track record . His experience includes in particular, work with such companies as Cascade Medical, Novartis Pharma Service AG, ARTERIUM, FIC medical and a Ukrainian law firm. Leonid’s previous position include positions of a manager for drug registration in Ukraine and CIS countries, Quality Assurance and medical counsel. His work for pharmaceutical companies was mainly focused on drug regulatory affairs, and his key duties included issues of liaison of the latter with national agencies for drug registration and quality control. He also acted as a counsel in numerous patent litigations.

“We are happy that Leonid joins our team. A professional lawyer with strong educational and practical background in the Life Science area and excellent reputation on the pharmaceutical market of Ukraine will help us to better match expectations of our clients – international and local companies in this industry. Life Science is one of the strategic sectors of Arzinger activity and we continue to invest into know-how development in this industry. Life Science businesses all over the world have been confronting over the years with a number of issues in three main legislative areas – regulatory, competition & antitrust, and IP. Ukraine is not an exception, – there are similar trends. Arzinger has an outstanding and recognized expertise in the regulatory and antitrust areas. Our IP practice has been just on the rise and we were not able toclaim leadership due to the limited capacities and lack of niche expertise in this area. Our IP – team has been assigned with the task to dramatically change this situation in order to enable us to provide our clients with an exhaustive complex of services on protection of their interests.

Considering aggressive policy of local and foreign generic companies in respect to original and generic products bio-equivalency of which have been confirmed by regulatory authorities of the USA and Europe and imperfection of Ukrainian legislation or the court practice in the IP sphere we see enormous opportunities in this area. Clients of Arzinger have already seen the synergy effect based on combination of Arzinger’s litigation experience and Leonid’s know-how in the area of patent law. Hard to overestimate is the fortunate combination of Leonid’s education in pharmacy and law which is very important for an expert focusing on patent disputes in the Life Science industry. Arzinger has ambitions to conquer leading positions in this sector and I’m sure that Leonid will help us to achieve the desired results”, – commented Timur Bondaryev, Managing Partner and Head of Arzinger’s Healthcare and Pharmaceutics Practice.

Lawyers are nominated for inclusion in the rankings by members of the Bar, Judiciary, and the senior management of large corporate and institutional clients.  Only attorneys engaged in the private practice of law are eligible to be included.  The United States Lawyer Rankings listing was established by a consortium of U.S. corporations in order to recognize those lawyers who have consistently provided the highest degree of legal representation, so that their members, as well as other businesses and individual clients, can have a degree of guidance and confidence when choosing to retain an attorney.

Lawyers are ranked based on confidential questionnaires regarding their negotiating skills, oral advocacy skills, and ability to develop creative solutions, and how much does the attorney add to the body of knowledge in his/ her practice area.  For a full listing of the 2012 United States Lawyer Rankings, follow the link provided below.

 http://www.unitedstateslawyerrankings.com/2012environmental.html    

For over 29 years, Bergman Dacey Goldsmith has been at the forefront of providing preventative risk counseling and the full spectrum of legal services to our clients.  To learn more about our award-winning attorneys and to review our experience portfolios, please visit our website at www.bdgfirm.com.   

The tug of war for bankrupt bakery giant Müller-Brot has concluded with the branch network of the chain going to a bidding partnership between the daughter of its founder and Munich bakery Höflinger.

With the unanimous agreement of the creditor’s committee, Müller and Höflinger will take over 148 branches with 435 employees from the insolvency administrator Dr Hubert Ampferl. Henceforth, the retail stores will be supplied by the two buyers.

When the planned sale of Müller-Brot to controversial owner Klaus Ostendorf fell through, Ampferl resumed negotiations with the initially unsuccessful partners Evi Müller and Francis Höflinger, alongside discussions with the Works Council. ……. Read more